Skip to main content
. Author manuscript; available in PMC: 2023 Apr 29.
Published in final edited form as: Biochem Soc Trans. 2022 Apr 29;50(2):689–701. doi: 10.1042/BST20200782

Table 1.

Notch pathway mutant mouse models

Experimental model Phenotype Gene expression of Notch target genes References
Downregulation Upregulation
Villin-CreERT2; N1F/F Increased goblet, enteroendocrine and Paneth cells.
Decreased LGR5+ and EdU+ cells.
Loss of Olfm4+ cells.
Hes1, Lgr5 and Olfm4 Math1, Ngn3, Spdef, Muc2, ChgA, Mmp7, Dll1 and Dll4 (34)
Villin-CreERT2; N2F/F Unaffected goblet cells Not reported No changes in Atoh1, ngn3, Muc2, ChgA, Mmp7, Dll1 and Dll4 (34)
Notch1/Notch2lox/lox-vil-Cre-ERT2

Villin-CreERT2; N1F/F/N2F/F (N1Δ;N2Δ/Δ)
Highly increased goblet cells.
Reduced Hes1+ cells.
Hes1 Muc2, Atoh1, Spdef, ChgA, Mmp7, Dll1 and Dll4 (31)

(34)
Dll1flox/flox vil-Cre-ERT2 Increased goblet cells Not reported Not reported (37)
Dll4flox/flox vil-Cre-ERT2 Unaffected goblet cells Not reported Not reported (37)
Dll1-Dll4vil-Cre-ERT2 Highly increased goblet cells.
Decreased Olfm4+ cells.
Loss of Lgr5+, Ascl2+, Hes1+ Ki67+ cells.
Inhibited NICD1 cleavage.
Not reported Math1 (37)
Villin-Cre;Adam10f/f
Villin-CreERT2;Adam10f/f
or organoids from different ADAM10 mutants
Increased goblet, Paneth, enteroendocrine and cleaved caspase-3+ cells.
Decreased enterocytes, BrdU+ and Ki67+ cells.
Hes1, HeyL and Olfm4 Tff3, Muc2, Cryptdins, Mmp7, ChgA, Atoh1, Gfi1, Spdef, Ngn3 and Sox9 (20)
γ-secretase inhibitors DBZ/DAPT treatment to mice models or mouse intestinal organoid Inhibited NICD1 expression.
Increased goblet, Paneth enteroendocrine, Tuft, SOX9+ and MATH1+ cells.
Decreased Ki67+ and HES1+ cells.
Olfm4 and Ascl2 Math1, Lysozyme, Mmp7, EphB3, Ngn3, Spdef, Gfi1, Tff3 and Prom1. (7, 3133, 64, 65, 78)
RBP-Jfloxed/floxed/P450-Cre
Rbpjlox/lox-vil-Cre-ERT2
RBP-Jvil-Cre-ERT2
Rbpjfl/fl:villin-creER
RbpjF/F:Villin-CreERT2
Increased goblet cells and MATH1+ cells.
Reduced HES1+ cells.
Loss of Lgr5+, Olfm4+, Acl2+, Hes6+ and Ki67+ cells.
Hes1 Math1 (32)
(31)
(37)
(64)
(34)
Vil-Cre;Rosa26DN-MAML/+ Increased goblet, Paneth and enteroendocrine cells. Decreased HES1+ and Ki67+ cells. Not reported Not reported (20)
Embryonic Hes1 KO
Hes1-KO pups
Villin-Cre;Hes1flox/–
Hes1fl/fl Cre-ERT2
Hes1fl/flVillin-Cre
Increased goblet, Paneth, cryptdin 4+ and cleaved caspase-3+ cells.
Decreases Ki67+ cells.
Reg3g, Saa1 and Reg3b Math1, Lysozyme, Cryptdin 1, 4 and 5 Gast, Gcg, Smst, Cck, Sct, Tph, Gip, ChgA, Atoh1, Isl1, Nkx2–2, Pax6, Pax4, Dll1, Dll3, Hes3, Hes5, Tbp, Atoh5 and Neurod1. (66)
(67)
(23)
(69)
(69)
Hes5 −/− Increased goblet cells Not reported Muc2, Dll1 and Fbw7β (68)
Villin-Cre;Hes1 flox/ ; Hes3 –/ ;Hes5 –/– Increased goblet, Paneth, enteroendocrine and cleaved caspase-3+ cell.
Decreased Ki67+ cells.
Not reported Not reported (23)
Math1β-Gal/-
Math1Δintestine/Lacz
Math1LoxP/LoxP/AHCre
Atoh1flox/flox:Fabp-Cre
Atoh1fl/fl;villin-creER
Lrig1CreERT2/+;Atoh1fl/fl
Decreased goblet, enteroendocrine and Paneth cells. Lack of cryptdins Not reported (72)
(76)
(65)
(78)
(64)
(75)

The name of each experimental mouse model is written as in the original article. The phenotype observed was based on histology, immunohistochemistry, Western analysis and flow cytometry. KO, knockout.